Company Data

InMed Pharmaceuticals Inc.

Ticker
INM
Current Price
$3.12 -7.96%
Market Cap
$2.1M
Price Target
Refer to Report
Volume
36.2K
52wk Range
$2.414 - $15.696
Advanced Market Data

Overview

InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy